This collection explores coined money and its uses over a wide area of the ancient Greek world. Written by numismatists and ancient historians, the papers cover a broad period from Archaic Greece to Roman Egypt. The collection offers fresh insights into this important aspect of the ancient economy.

The papers in this volume reassess the role of coined money in the ancient Greek world. Using new approaches, the book makes the results of numismatic as well as historical research accessible to students and scholars of ancient history. The chapters provide a wide-ranging account of the political, social, and economic contexts within which coined money was used. In Part One the book focuses on the theme of monetization and the politics of coinage, while Part Two provides a series of case studies relating to the production and use of coined money in different areas of the Greek-speaking world, including Asia Minor, Egypt, and Rhodes as well as Greece itself. The individual chapters cover a broad chronological range from Archaic Greece to Roman Egypt. The book as a whole offers fresh insights into an important aspect of the ancient Greek economy.

Humanity is at the brink of a biological revolution. In the year 2011, only the tip of the biological iceberg has revealed itself. The next several decades will unveil an unprecedented rate of technological advance, particularly in the fields of genomics and proteomics. While understanding the genome is the essential first step towards this revolution, the real development and exploitation of this technology will happen via proteomics. The Human Proteome Project is the critical bridge between knowledge of the genome and full operationalization of tactics and techniques to manipulate biological processes in very deliberate and specific ways. These findings will create synergies leading to the specific and precise exploitation of genetic data. The project will yield such comprehensive knowledge of the biological and molecular function of human life that medical diagnosis and intervention will be radically altered. Future biological technology has the potential for both good and evil. Primarily seen as medical research and a path to development of better medications, the majority of research occurs at either pharmaceutical firms or other public research centers. Some of these entities are state sponsored and others are university affiliated, but advances in medical science appear to be the primary driver for the majority of this work.